Analyst Price Targets — OPK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 30, 2025 8:10 pm | — | Jefferies | $1.60 | $1.46 | TheFly | Opko Health downgraded to Hold from Buy at Jefferies |
| September 17, 2024 6:52 am | Yi Chen | H.C. Wainwright | $3.00 | $1.70 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK) |
| December 15, 2022 6:56 am | — | H.C. Wainwright | $3.00 | $1.29 | Benzinga | HC Wainwright & Co. Initiates Coverage On OPKO Health with Buy Rating, Announces Price Target of $3 |
| August 4, 2022 8:38 pm | Edward Tenthoff | Piper Sandler | $4.00 | $2.40 | TheFly | Opko Health price target lowered to $4 from $5 at Piper Sandler |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for OPK

OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th.

OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a summary of

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OPK.
U.S. House Trading
No House trades found for OPK.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
